AMAG Pharmaceuticals Inc (AMAG)

33.85
NASDAQ : Health Care
Prev Close 33.85
Day Low/High 0.00 / 0.00
52 Wk Low/High 17.92 / 36.23
Avg Volume 759.50K
Exchange NASDAQ
Shares Outstanding 34.21M
Market Cap 1.14B
EPS 1.00
P/E Ratio 8.49
Div & Yield N.A. (N.A)

Latest News

AMAG Makes Notable Cross Below Critical Moving Average

AMAG Makes Notable Cross Below Critical Moving Average

In trading on Friday, shares of AMAG Pharmaceuticals, Inc. crossed below their 200 day moving average of $24.16, changing hands as low as $23.74 per share.

Commit To Buy AMAG Pharmaceuticals At $20, Earn 15.6% Annualized Using Options

Commit To Buy AMAG Pharmaceuticals At $20, Earn 15.6% Annualized Using Options

Investors considering a purchase of AMAG Pharmaceuticals, Inc. stock, but tentative about paying the going market price of $24.29/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Bullish Two Hundred Day Moving Average Cross - AMAG

Bullish Two Hundred Day Moving Average Cross - AMAG

In trading on Thursday, shares of AMAG Pharmaceuticals, Inc. crossed above their 200 day moving average of $24.42, changing hands as high as $24.60 per share.

Today's Perilous Reversal Stock: AMAG Pharmaceuticals (AMAG)

Today's Perilous Reversal Stock: AMAG Pharmaceuticals (AMAG)

Trade-Ideas LLC identified AMAG Pharmaceuticals (AMAG) as a "perilous reversal" (up big yesterday but down big today) candidate

First Week of February 2017 Options Trading For AMAG Pharmaceuticals (AMAG)

First Week of February 2017 Options Trading For AMAG Pharmaceuticals (AMAG)

Investors in AMAG Pharmaceuticals, Inc. saw new options begin trading this week, for the February 2017 expiration.

Practice Patience With AMAG Pharma

The daily chart flashes hope as bulls push out of a bullish flag.

AMAG Pharmaceuticals Becomes Oversold (AMAG)

AMAG Pharmaceuticals Becomes Oversold (AMAG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Allergan Could Buy These Drug Companies Now That the Pfizer Merger Is Scuttled

Allergan Could Buy These Drug Companies Now That the Pfizer Merger Is Scuttled

Now that the Allergan-Pfizer merger is off, Allergan CEO Saunders could start shopping again for biotech and smaller pharma companies to fuel his company's growth.

AMAG Pharmaceuticals Announces The U.S. Commercial Launch Of New Single-Dose, Preservative-Free Makena® (hydroxyprogesterone Caproate Injection)

AMAG Pharmaceuticals Announces The U.S. Commercial Launch Of New Single-Dose, Preservative-Free Makena® (hydroxyprogesterone Caproate Injection)

Company also Announces Expansion of Home Healthcare Support through Makena Care Connection

Trade-Ideas: AMAG Pharmaceuticals (AMAG) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: AMAG Pharmaceuticals (AMAG) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified AMAG Pharmaceuticals (AMAG) as a strong on high relative volume candidate

AMAG Pharmaceuticals Stock Sees Short Interest Jump 14%

AMAG Pharmaceuticals Stock Sees Short Interest Jump 14%

The most recent short interest data has been released by the NASDAQ for the 03/15/2016 settlement date, which shows a 1,095,548 share increase in total short interest for AMAG Pharmaceuticals, Inc. , to 8,886,140, an increase of 14.06% since 02/29/2016.

AMAG Pharmaceuticals (AMAG) Showing Signs Of A Dead Cat Bounce Today

AMAG Pharmaceuticals (AMAG) Showing Signs Of A Dead Cat Bounce Today

Trade-Ideas LLC identified AMAG Pharmaceuticals (AMAG) as a "dead cat bounce" (down big yesterday but up big today) candidate